SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-077648
Filing Date
2013-10-24
Accepted
2013-10-24 16:23:55
Documents
8
Period of Report
2013-10-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-17392_108k.htm 8-K 33575
2 EX-1.1 a13-17392_10ex1d1.htm EX-1.1 342592
3 EX-99.1 a13-17392_10ex99d1.htm EX-99.1 10738
4 EX-99.2 a13-17392_10ex99d2.htm EX-99.2 11167
5 GRAPHIC g1739210mmi001.jpg GRAPHIC 3396
6 GRAPHIC g1739210mmi002.jpg GRAPHIC 856
7 GRAPHIC g1739210moi001.jpg GRAPHIC 3415
8 GRAPHIC g1739210moi002.jpg GRAPHIC 856
  Complete submission text file 0001104659-13-077648.txt   411540
Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 131168417
SIC: 2834 Pharmaceutical Preparations